Potential biomarker emerging for diabetic neuropathy

Nervous system

An emerging biomarker may eventually lead to new approaches for treating diabetics at risk of developing nerve damage, UNSW researchers have found.

The researchers say neuropathy in is under-diagnosed and early identification has been problematic. It is estimated that up to 50 per cent of diabetics end up with nerve damage.

They tested excitability in diabetics with and without neuropathy and found those without irreversible still showed excitability abnormalities well before the development of clinical symptoms.

“Excitability testing provides a to identify the early development and severity of diabetic neuropathy,” the key researcher Dr Cindy Lin said.

The research was led by UNSW and the School of Medical Science’s Dr Cindy Lin and is published in the journal Diabetes.

Professor Matthew Kiernan from UNSW says the research may lead to new therapeutic approaches for treating patients with diabetic neuropathy early.

“It may yet prove possible to initiate therapy in diabetic patients well before they manifest the neurological symptoms and disability that inevitably reflects the presence clinical neuropathy,” Professor Kiernan says in his commentary, also published in Diabetes.

“Pharmacological manipulation of axonal membrane channels seems likely to provide further new therapeutic approaches for treating patients with diabetic neuropathy,” he says.

add to favorites email to friend print save as pdf

Related Stories

Bone marrow cells can heal nerves in diabetes model

Feb 04, 2009

Transplanting cells that replenish blood vessels can also restore nerve function in an animal model of diabetic neuropathy, Emory researchers have found. The results are described online this week in the journal Circulation.

Recommended for you

Blood glucose levels set for achieving HbA1c targets

Apr 11, 2014

(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according ...

Women with diabetes less likely to have a mammogram

Apr 11, 2014

Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's ...

User comments